| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OMCL | Common Stock | Purchase | $350K | +10.6K | +3.27% | $33.13 | 334K | 14 Mar 2025 | Direct | F3 |
| transaction | OMCL | Common Stock | Award | $0 | +79.5K | +23.83% | $0.00 | 413K | 15 Mar 2025 | Direct | F4 |
| holding | OMCL | Common Stock | 356K | 14 Mar 2025 | In Trust with Wife | F1 | |||||
| holding | OMCL | Common Stock | 8.05K | 14 Mar 2025 | In Trust for Children | F2 |
| Id | Content |
|---|---|
| F1 | Shares held in trust with Mr. Lipps' wife. |
| F2 | Shares held in trust for the benefit of Mr. Lipps' children. |
| F3 | The price reported in Column 4 is a weighted average price of $33.1289 The purchase price range between $32.745 to $33.44 The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F4 | Restricted Stock Units granted in connection with the Issuer's equity incentive plan. One-fourth (25%) of the shares subject to the grant shall vest on March 15, 2026. The remaining three-fourths (75%) of the shares subject to the grant shall vest quarterly over three years on: (i) 5/15; (ii) 8/15; (iii) 11/15; and (iv) 2/15. |